Allergic Rhinitis: Clinical Development Programs for Drug Products | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2000-D-0277

Allergic Rhinitis: Clinical Development Programs for Drug Products

Documents

Comments

Description

Docket Status: OPEN

Comment Period OpensFeb 16, 2016

Comment Period ClosesApr 19, 2016

Type	Title	Posted	Comments	Status
Other	Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry	Sep 6, 2018	--

Total Comments

NDA'S

ORAL & TRANASAL

CHILDREN AND ALDULTS

PERENNIAL ALLERGIES (PAR)

SEASONAL ALLERGIES (SAR)

ALLERGIC RHINITIS

DRUG PRODUCTS